DoseMeRx
Overview
DoseMeRx is the world’s first and largest Bayesian dosing platform designed for clinical practice, offering clinically-validated pharmacokinetic models and patient data to provide accurate individualized drug doses. It aims to help clinicians spend more time on patients and less on calculations, reaching clinical targets faster, improving patient outcomes, and lowering costs.
The platform supports a diverse range of drug models across various therapeutic areas, including vancomycin and infectious disease, transplant medicine, cardiovascular and coagulation management, oncology, and pediatrics. It emphasizes ease of implementation with a simple, staged process and provides 24/7 customer support from real people.
DoseMeRx is committed to data security, being the only HITRUST CSF certified Bayesian dosing platform globally, ensuring the highest level of patient data security and integrity by addressing all standards and implementations in the HIPAA Security Rule. It also helps simplify AUC compliance and workflows, enabling continuity of care and optimization of therapeutic drug monitoring programs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Bayesian Dosing Platform
- Clinically-validated Pharmacokinetic/Pharmacodynamic (PK/PD) Models
- Individualized Drug Dosing
- Diverse Range of Drug Models (Vancomycin, Oncology, Infectious Disease, Transplant, Cardiovascular, Coagulation, Pediatrics)
- Web-based Platform & EHR Integrations (Epic, Cerner, VigiLanz, Sentri7)
- Analytics & Real-time Dashboards (Clinical and Usage Data, Trough vs. AUC outcomes, patient risk, time to therapeutic targets)
- 24/7 Customer Support from real people
- HITRUST CSF Certified (Data Security & HIPAA Compliance)
- Simplifies AUC Compliance & Workflows
- Dose Simulation and Alternative Dosing Matrix
Use Cases
- Optimizing antimicrobial therapy (e.g., vancomycin, aminoglycosides)
- Reducing incidence of acute kidney injury (AKI)
- Achieving clinical targets faster and improving patient outcomes
- Standardizing therapeutic drug monitoring (TDM) programs
- Cost-effectiveness in patient care (e.g., shorter hospitalization)
- Supporting personalized treatment with genetic biomarker capabilities
What Physicians Need to Know
Utilize DoseMeRx for individualized dosing of narrow therapeutic index drugs, especially vancomycin, to achieve target AUCs and reduce adverse events like acute kidney injury. Leverage its ability to interpret pre-steady state drug levels and flexible sample collection times to optimize patient care without delaying therapy. Integrate the tool into your daily workflow to streamline calculations and focus more on patient assessment and management. Review the analytics dashboards to monitor institutional dosing practices and patient outcomes.
DoseMeRx offers robust integration capabilities with major EHR systems (Epic, Cerner) via SMARTu00ae and FHIRu00ae standards, enabling automatic patient data extraction and embedding dosing recommendations directly within the EHR interface. It also integrates with pharmacy surveillance software (VigiLanz, Sentri7) to enhance continuous safety monitoring and antimicrobial stewardship efforts, minimizing manual data entry and optimizing workflow efficiency.
Details
| Category | Pharmacology & Dosing AI |
| Pricing | Contact for pricing |
| Deployment | Web-based, EHR integrated |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated DoseMeRx is a regulatory-cleared medical device with CE mark (European Conformity) and TGA ARTG (Australian Register of Therapeutic Goods) listing, and is also FDA compliant. |
| Integrations | |
| EHR | Not specified |
| Specialties | Critical Care, Infectious Disease, Oncology |
What the Web Says
DoseMeRx is a widely adopted Bayesian precision dosing platform, particularly for hospital pharmacists and nephrologists managing drug dosing in patients with renal impairment. It is highly regarded for its ability to optimize dosing for narrow therapeutic index drugs like vancomycin, aminoglycosides, and immunosuppressants, aligning with guidelines such as the 2020 ASHP/IDSA vancomycin recommendations. The platform is integrated with major EHR systems and deployed in over 300 hospitals globally, aiming to improve patient outcomes and reduce costs.
Overall: PositiveStrengths
- Provides precise, tailored dosing calculations using a Bayesian approach.
- Clinically validated and evidence-based technology.
- Saves clinician time on calculations and improves productivity.
- Helps reduce adverse drug events like AKI and improves patient safety.
- Seamless integration with major EHR systems.
- Easy to learn and navigate for staff.
Limitations
- Enterprise-only pricing, making it inaccessible to individual physicians.
- Some older pharmacists may be distrustful of the software and the new process.
- Requires training for effective use and understanding of the protocol.
- Limited to specific medical fields (specialized precision dosing, not a general clinical decision support tool).
- Does not currently take into consideration multiple drug use which might change dosing.
- Nurses may not pay attention to appropriate lab collection for trough levels when transitioning to AUC-based dosing.
Based on reviews from: Clinical AI Report, G2, SourceForge, Spotsaas, SaaSworthy, IDStewardship, Reddit, YouTube, Inovalon
Last updated: 2026-08-06
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate DoseMeRx
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for DoseMeRx.
Understanding DoseMe | Precision Dosing Platform
Life Sciences 360
